NEWYou can now listen to Fox News articles!

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests.

Researchers at UC San Diego studied more than 6,800 patients who were taking one of these popular similar diabetes and weight-loss medications.

They found that the patients were much less likely to die within five years than those who weren’t taking the drugs.

WHY MICRODOSING OZEMPIC COULD BECOME AS COMMON AS TAKING A MULTIVITAMIN

Only about 15% of GLP-1 users died within five years compared with 37% of non-users, according to a press release.

The survival benefit was seen even after accounting for factors like age, cancer severity and other medical issues, the researchers found.

“The central message is that GLP-1 medications wer

See Full Page